127 related articles for article (PubMed ID: 2124772)
1. Development of a screening system for cystic fibrosis: meconium or blood spot trypsin assay or both?
Pederzini F; Faraguna D; Giglio L; Pedrotti D; Perobelli L; Mastella G
Acta Paediatr Scand; 1990 Oct; 79(10):935-42. PubMed ID: 2124772
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening strategy for cystic fibrosis: a field study in an area with high allelic heterogeneity.
Castellani C; Bonizzato A; Cabrini G; Mastella G
Acta Paediatr; 1997 May; 86(5):497-502. PubMed ID: 9183489
[TBL] [Abstract][Full Text] [Related]
3. [Mucoviscidosis screening with immunoreactive trypsin].
Eber E; Ellemunter H; Engele H; Götz M; Grünberger W; Haas J; Janisch H; Leodolter S; Litscher H; Müller G
Wien Klin Wochenschr; 1992; 104(22):681-5. PubMed ID: 1475973
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactive trypsin levels in neonates with meconium ileus.
Steven LC; Gavel G; Young D; Carachi R
Pediatr Surg Int; 2006 Mar; 22(3):236-9. PubMed ID: 16395608
[TBL] [Abstract][Full Text] [Related]
5. Elevated meconium lactase activity. Its use as a screening test for cystic fibrosis.
Berry HK; Kellogg FW; Lichstein SR; Ingberg RL
Am J Dis Child; 1980 Oct; 134(10):930-4. PubMed ID: 6775525
[TBL] [Abstract][Full Text] [Related]
6. CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test.
Castellani C; Bonizzato A; Mastella G
J Med Genet; 1997 Apr; 34(4):297-301. PubMed ID: 9138152
[TBL] [Abstract][Full Text] [Related]
7. Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots.
Crossley JR; Smith PA; Edgar BW; Gluckman PD; Elliott RB
Clin Chim Acta; 1981 Jun; 113(2):111-21. PubMed ID: 7249357
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants.
Wilcken B; Brown AR; Urwin R; Brown DA
J Pediatr; 1983 Mar; 102(3):383-7. PubMed ID: 6827410
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis screening in neonates--measurement of immunoreactive trypsin and direct genotype analysis for delta F508 mutation.
Larsen J; Campbell S; Faragher EB; Götz M; Eichler I; Waldherr S; Dobianer K; Spona J
Eur J Pediatr; 1994 Aug; 153(8):569-73. PubMed ID: 7957403
[TBL] [Abstract][Full Text] [Related]
10. Assay of serum immunoreactive trypsin in dried blood spots and the early detection of cystic fibrosis.
Ryley HC; Robinson PG; Yamashiro Y; Bradley DM
J Clin Pathol; 1981 Aug; 34(8):906-10. PubMed ID: 7276210
[TBL] [Abstract][Full Text] [Related]
11. [Mucoviscidosis screening with immunoreactive trypsin. Initial experiences in Austria].
Eber E; Zach M; Engele H; Haas J; Pürstner P; Mutz I; Litscher H
Monatsschr Kinderheilkd; 1992 Jul; 140(7):411-5. PubMed ID: 1501616
[TBL] [Abstract][Full Text] [Related]
12. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two different protocols of neonatal screening for cystic fibrosis.
Narzi L; Lucarelli M; Lelli A; Grandoni F; Lo Cicero S; Ferraro A; Matarazzo P; Delaroche I; Quattrucci S; Strom R; Antonelli M
Clin Genet; 2002 Sep; 62(3):245-9. PubMed ID: 12220442
[TBL] [Abstract][Full Text] [Related]
14. Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies.
Wilcken B; Wiley V; Sherry G; Bayliss U
J Pediatr; 1995 Dec; 127(6):965-70. PubMed ID: 8523199
[TBL] [Abstract][Full Text] [Related]
15. Screening for cystic fibrosis in dried blood spots of newborns.
Audrézet MP; Costes B; Ghanem N; Fanen P; Verlingue C; Morin JF; Mercier B; Goossens M; Férec C
Mol Cell Probes; 1993 Dec; 7(6):497-502. PubMed ID: 8145780
[TBL] [Abstract][Full Text] [Related]
16. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
Padoan R; Bassotti A; Seia M; Corbetta C
Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388
[TBL] [Abstract][Full Text] [Related]
17. Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step.
Pollitt RJ; Dalton A; Evans S; Hughes HN; Curtis D
J Med Screen; 1997; 4(1):23-8. PubMed ID: 9200059
[TBL] [Abstract][Full Text] [Related]
18. Neonatal cystic fibrosis screening: Analysis and differences in immunoreactive trypsin levels in newborns with a positive screen.
Arrudi-Moreno M; García-Romero R; Samper-Villagrasa P; Sánchez-Malo MJ; Martin-de-Vicente C
An Pediatr (Engl Ed); 2021 Jul; 95(1):11-17. PubMed ID: 34140271
[TBL] [Abstract][Full Text] [Related]
19. [Regional mucoviscidosis screening using immunoreactive trypsin in umbilical cord blood].
Ploier R; Emhofer J; Licka B; Rezanka E; Turnher H
Padiatr Padol; 1991; 26(6):263-6. PubMed ID: 1792095
[TBL] [Abstract][Full Text] [Related]
20. [Mucoviscidosis screening by determination of immunoreactive trypsin].
Sander J; Niehaus C
Klin Padiatr; 1984; 196(4):224-7. PubMed ID: 6482307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
